Doxorubicin-sanguinarine nanoparticles: Formulation and evaluation of breast cancer cell apoptosis and cell cycle
Conclusions: Cellular and molecular studies suggested adjuvant chemosensitizers SA and SN to reverse MDR in breast cancer cells.PMID:38180322 | DOI:10.1080/03639045.2024.2302557
Source: Drug Development and Industrial Pharmacy - Category: Drugs & Pharmacology Authors: Mahmoud Zaki El-Readi Majed Abdurhman Abdulkarim Ahmed A H Abdellatif Mohamed E Elzubeir Bassem Refaat Mohammad Althubiti Riyad Adnan Almaimani Mohammed Hasan Mukhtar Issa Saad Al-Moraya Safaa Yehia Eid Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Drugs & Pharmacology | Genetics | Nanotechnology | Study | Toxicology